Holen Sie sich die Stockscreener-App
50.95
0.25%
-0.105
Schlusskurs vom Vortag:
$51.06
Offen:
$51.16
24-Stunden-Volumen:
1.09M
Relative Volume:
0.57
Marktkapitalisierung:
$10.49B
Einnahmen:
$2.07B
Nettoeinkommen (Verlust:
$405.37M
KGV:
26.11
EPS:
1.9513
Netto-Cashflow:
$472.50M
1W Leistung:
-0.59%
1M Leistung:
+7.79%
6M Leistung:
+4.00%
1J Leistung:
+26.88%
1-Tages-Spanne:
$50.71
$51.59
1-Wochen-Bereich:
$50.52
$51.71
52-Wochen-Spanne:
$37.74
$57.81
Qiagen Nv Stock (QGEN) Company Profile
Firmenname
Qiagen Nv
Sektor
Branche
Telefon
-
Adresse
-
Compare QGEN vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
50.91 | 10.52B | 2.07B | 405.37M | 472.50M | 1.9513 |
|
TMO
Thermo Fisher Scientific Inc
|
509.25 | 198.06B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
216.00 | 155.50B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
618.37 | 51.80B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
124.87 | 36.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
318.94 | 32.29B | 3.11B | 648.81M | 602.27M | 10.88 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-22 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-04 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-06-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-12-07 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Hochstufung | DZ Bank | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-10-14 | Eingeleitet | Redburn | Buy |
| 2021-07-14 | Herabstufung | Kepler | Buy → Hold |
| 2021-06-03 | Eingeleitet | Goldman | Neutral |
| 2020-10-06 | Fortgesetzt | BofA Securities | Buy |
| 2020-09-28 | Hochstufung | Kepler | Hold → Buy |
| 2020-08-24 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-17 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Herabstufung | Berenberg | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-12-26 | Fortgesetzt | BofA/Merrill | Underperform |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-11-14 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Hochstufung | Kepler | Reduce → Hold |
| 2019-10-17 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Herabstufung | Kepler | Hold → Reduce |
| 2019-10-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
QIAGEN NV : Buy rating from Berenberg - marketscreener.com
QIAGEN Is Unleashing a Powerful Product Expansion Strategy — And It’s Reshaping Growth! - Smartkarma
Goldman Sachs Discloses 3.06% Stake in Qiagen via AFM Filing - TipRanks
Release according to Article 40, Section 1 of the WpHG - TradingView
UBS Adjusts QIAGEN Price Target to $52 From $50, Maintains Neutral Rating - marketscreener.com
Qiagen N.V. $QGEN Shares Sold by Nuance Investments LLC - MarketBeat
Qiagen N : Fourth Quarter 2025 Transcript - marketscreener.com
Entry Recap: Is Qiagen NV backed by strong institutional buyingWeekly Investment Report & Expert Verified Movement Alerts - baoquankhu1.vn
Qiagen targets 9% growth in 2026 growth pillars and $2B by 2028 with new product launches - MSN
Qiagen Q4 Earnings Call Highlights - MarketBeat
Qiagen N.V. (NYSE:QGEN) Q4 2025 Earnings Call Transcript - Insider Monkey
Qiagen (QGEN) PT Raised by JP Morgan Amid Overweight Rating | QG - GuruFocus
JPMorgan Chase & Co. Boosts Qiagen (NYSE:QGEN) Price Target to $60.00 - MarketBeat
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Stifel raises Qiagen stock price target to $50 on growth outlook By Investing.com - Investing.com South Africa
Citigroup Cuts Qiagen (NYSE:QGEN) Price Target to $55.00 - MarketBeat
QGEN Analyst Rating: Citigroup Maintains Neutral, Lowers Price T - GuruFocus
Qiagen (QGEN): Stifel Raises Price Target to $50, Maintains Hold Rating | QGEN Stock News - GuruFocus
Stifel raises Qiagen stock price target to $50 on growth outlook - Investing.com
Qiagen NV (QGEN) PT Raised to $50 at Stifel - StreetInsider
Qiagen: 2025 ended positively, entering 2026 with confidence - marketscreener.com
QGEN's Q4 Earnings Meet Estimates, Revenues Up Y/Y, Stock Down - TradingView
Qiagen Tops 2025 Guidance and Sets Ambitious 2026 Growth Targets - TipRanks
QIAGEN (NYSE: QGEN) tops 2025 targets and guides for at least 5% CER sales growth in 2026 - Stock Titan
QIAGEN NV : Jefferies reaffirms its Buy rating - marketscreener.com
Jefferies Maintains Buy on Qiagen N.V. (QGEN) Feb 2026 - Meyka
Qiagen (QGEN) Exceeds Q4 2025 Expectations with Strong Financial Performance - GuruFocus
Qiagen NV (QGEN) Q4 2025 Earnings Call Highlights: Strong Growth Amidst Challenges - GuruFocus
Qiagen NV (QGEN) Q4 2025 Earnings Call Highlights: Strong Growth Amidst Challenges By GuruFocus - Investing.com Canada
Investors Purchase Large Volume of Call Options on Qiagen (NYSE:QGEN) - MarketBeat
Allianz Asset Management GmbH Purchases 534,527 Shares of Qiagen N.V. $QGEN - MarketBeat
QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars - BioSpace
QIAGEN NV : Jefferies maintains a Buy rating - marketscreener.com
Goldman Sachs Reports 3.11% Stake in QIAGEN via Shares and Derivatives - The Globe and Mail
Qiagen reports Q4 sales USD 540 mln - marketscreener.com
BlackRock Discloses Significant Stake in QIAGEN - The Globe and Mail
Qiagen (QGEN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Qiagen: Q4 Financial Results Overview - Bitget
Qiagen (QGEN) Meets Q4 Earnings Estimates - Yahoo Finance
Qiagen (NYSE:QGEN) Announces Earnings Results - MarketBeat
Qiagen (NYSE:QGEN) Updates Q1 2026 Earnings Guidance - MarketBeat
Qiagen (NYSE:QGEN) Issues FY 2026 Earnings Guidance - MarketBeat
Qiagen: Q4 Earnings Snapshot - kare11.com
Qiagen guides to at least 5% sales growth in 2026 By Investing.com - Investing.com Nigeria
Qiagen guides to at least 5% sales growth in 2026 - Investing.com
Qiagen faces earnings test as analyst estimates slide 15% despite takeover chatter - Investing.com
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - Pressetext
QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026 - BioSpace
Aug Mood: Should I set a stop loss on Qiagen N.VEarnings Overview Report & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Examining the Future: Qiagen's Earnings Outlook - Benzinga
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Finanzdaten der Qiagen Nv-Aktie (QGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):